Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DRKS00034116Phase 3Active, not recruiting
Phase 3, randomised trial of triamcinolone and lidocaine in lumbosacral radiculopathy and diskogenic radiculopathy (2 arms), sponsored by Radtop. Primary endpoint: Improvement in pain. Started Jun 2024; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on DRKS00034116.